In addition to the antitumor effects dependent on DNMT inhibition, AZA proved to revert the pro-metastatic phenotype in NSCLC cell lines, suggesting a role for this DNMT inhibitor in preventing metastasis formation [26]. Here, DNMT1 is linked to non-small cell lung carcinoma.